Table 2.
Follow-up, months | |
Median | 13.8 |
Range | 0–21 |
Local control | 38 (100%) |
Disease-free survival after 1 year | 83% |
Tumor shrinkage after 1 year, mm | |
Median | 22 |
Range | 4–59 |
Recurrence, n | |
In-field | 0 |
Regional lymph nodes | 4 (10.5%) |
Distant | 3 (8%) |
Radiation pneumonitis, n | |
Radiographic | 34 (89.5%) |
Clinical | 2 (5%) |
Chest pain | 16 (44%) |
Dyspnea | 2 (5%) |